Cost-Effectiveness of Maintaining Higher Stem-Cell Collection Thresholds in the Chimeric Antigen Receptor T-Cell Era for Multiple Myeloma Predicting severe adverse events (SAEs) in oncology is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results